Health Technology Assessment: HTA Coordination Group publishes its 2025 Annual Report
The Member State Coordination Group on Health Technology Assessment (HTACG) has published its 2025 Annual Report, providing an overview of the first year of application of the EU Health Technology Assessment Regulation.
The report presents the key achievements of the HTACG and its four subgroups in 2025, covering joint clinical assessments, joint scientific consultations and the involvement of experts in these cases. It also covers the work undertaken on the identification of emerging health technologies and the development of methodological and procedural guidance, as well as communication activities with key stakeholders.
In 2025, the HTACG started 13 joint clinical assessments on new oncology products and advanced therapy medicinal products. The report outlines the preparatory work undertaken to start the joint clinical assessment of medical devices and in vitro diagnostic medical devices beginning in 2026. The Group has selected seven joint scientific consultations across two request periods in 2025, including four consultations in parallel with the provision of scientific advice by the European Medicines Agency (EMA). Four joint scientific consultations were completed in 2025.
By the end of 2025, 38 patients, carers or clinicians were involved in joint clinical assessments and 10 in joint scientific consultations. The Annual Report fulfils the requirement under Article 6(4) of the EU Health Technology Assessment Regulation and provides transparency on the functioning of the EU HTA framework.
More information: